Mechanisms of myocardial reperfusion injury

被引:256
|
作者
Park, JL [1 ]
Lucchesi, BR [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA
来源
ANNALS OF THORACIC SURGERY | 1999年 / 68卷 / 05期
关键词
D O I
10.1016/S0003-4975(99)01073-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Reperfusion of the ischemic myocardium results in irreversible tissue injury and cell necrosis, leading to decreased cardiac performance. While early reperfusion of the heart is essential in preventing further tissue damage due to ischemia, reintroduction of blood flow can expedite the death of vulnerable, but still viable, myocardial tissue, by initiating a series of events involving both intracellular and extracellular mechanisms. In the last decade, extensive efforts have focused on the role of cytotoxic reactive oxygen species, complement activation, neutrophil adhesion, and the interactions between complement and neutrophils during myocardial reperfusion injury. Without reperfusion, myocardial cell death evolves slowly over the course of hours. In contrast, reperfusion after an ischemic insult of sufficient duration initiates an inflammatory response, beginning with complement activation, followed by the recruitment and accumulation of neutrophils into the reperfused myocardium. Modulation of the inflammatory response, therefore, constitutes a potential pharmacological target to protect the heart from reperfusion injury. Recognition of the initiating factor(s) involved in myocardial reperfusion injury should aid in development of pharmacological interventions to selectively or collectively attenuate the sequence of events that mediate extension of tissue injury beyond that caused by the ischemic insult. (C) 1999 by The Society of Thoracic Surgeons.
引用
收藏
页码:1905 / 1912
页数:8
相关论文
共 50 条
  • [31] Nitrite and myocardial reperfusion injury
    Lefer, David J.
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2009, 20 : S26 - S26
  • [32] FLUOSOL IN MYOCARDIAL REPERFUSION INJURY
    MURRAY, JJ
    VITOLA, JV
    SCHAER, GL
    FORMAN, MB
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (07) : 1742 - 1743
  • [33] Myocardial ischemia - reperfusion injury
    Salo, S., V
    Shumakov, V. O.
    Shpak, S. S.
    Tokhtarov, V. V.
    ZAPOROZHYE MEDICAL JOURNAL, 2023, 25 (05) : 455 - 460
  • [34] Neutrophils and myocardial reperfusion injury
    Williams, FM
    PHARMACOLOGY & THERAPEUTICS, 1996, 72 (01) : 1 - 12
  • [35] VASONATRINPEPTIDE ATTENUATES MYOCARDIAL ISCHEMIA/REPERFUSION INJURY IN DIABETIC RATS AND UNDERLYING MECHANISMS
    Wang, W. Z.
    Shi, Z. W.
    Fu, F.
    Yu, L. M.
    Wang, K.
    Liang, X. Y.
    Zhang, H. F.
    CARDIOLOGY, 2015, 131 : 287 - 287
  • [36] Pathophysiology of myocardial reperfusion injury
    Piper, H. M.
    Kasseckert, S. A.
    Schluter, K. -D.
    Abdallah, Y.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2008, 133 (12) : 586 - 590
  • [37] Mechanisms and Therapeutic Strategies for Myocardial Ischemia-Reperfusion Injury in Diabetic States
    Xue, Jing
    Zhuang, Jialu
    Wang, Xinyue
    Meng, Tao
    Wu, Jin
    Zhang, Xiaoqian
    Zhang, Guiyang
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2024, 7 (12) : 3691 - 3717
  • [38] Mechanisms of Paeoniflorin against myocardial ischemia reperfusion injury based on network pharmacology
    Zhao, Chengguo
    Yin, Meifang
    Li, Feng
    Ling, Wenpei
    Luo, Chunyu
    Qin, Shuzhi
    MATERIALS EXPRESS, 2021, 11 (09) : 1505 - 1515
  • [39] Mechanisms, management and future directions for reperfusion injury after acute myocardial infarction
    Richard O Cannon
    Nature Clinical Practice Cardiovascular Medicine, 2005, 2 : 88 - 94
  • [40] microRNA regulatory mechanisms of mitoKATP in myocardial ischaemia-reperfusion injury in rats
    Nie, J.
    Deng, M.
    Wang, H.
    Yu, T.
    BRITISH JOURNAL OF ANAESTHESIA, 2019, 122 (03) : E35 - E36